Counselors in Jamesburg, NJ Accepting Medicare

7 Counselors found. Showing 1 - 7

Marguerite Villepontoux Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 79 E Railroad Ave, Jamesburg, NJ 08831 Phone: 732-561-8555    Fax: 732-561-1165

Sade Ashanti Glenn, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 79 E Railroad Ave, Jamesburg, NJ 08831 Phone: 732-561-8555

Mrs. Alla Krutyansky, MSW, LSW Counselor - Mental Health Medicare: Accepting Medicare Assignments Practice Location: 79 E Railroad Ave, Jamesburg, NJ 08831 Phone: 732-561-8555    Fax: 973-836-0349

Laura Sansum, LAC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 79 E Railroad Ave, Jamesburg, NJ 08831 Phone: 732-561-8555

Lauren N Bennett, MS Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 79 E Railroad Ave, Jamesburg, NJ 08831 Phone: 732-561-8555

Leslie F Small, MS LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 9 Davison Ave, Suite #3, Jamesburg, NJ 08831 Phone: 732-997-0214

Alison Summer Iris Slater Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 79 E Railroad Ave, Jamesburg, NJ 08831 Phone: 732-561-8555

News Archive

Researchers elucidate central mechanisms of salt-induced hypertension through sympathetic activation

Hypertension is a major risk factor for cardiovascular disease worldwide, and approximately 40% (1 billion) of adults aged 25 and above have been diagnosed with hypertension. A positive correlation between salt intake and blood pressure has long been postulated.

Study aims at determining optimal dose of nab-paclitaxel with carboplatin as first-line therapy for NSCLC

The June edition of the Journal of Thoracic Oncology features a study aimed at determining the optimal dose of the chemotherapy drug nab-paclitaxel with carboplatin as a first-line therapy in patients with non-small cell lung cancer. Results will provide researchers with a data needed to guide a phase 3 trial.

Four teams receive commercialization grant awards for development of new health-care products

Four Washington-based teams of investigators will receive up to $150,000 each to support commercial development of new health and health-care products, the Life Sciences Discovery Fund announced today.

Codexis files registration statement with SEC for proposed initial public offering of common stock

Codexis, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to the proposed initial public offering of shares of its common stock.

Read more Medical News

› Verified 6 days ago